Literature DB >> 23267868

Gastroesophageal reflux disease treatment: side effects and complications of fundoplication.

Joel E Richter1.   

Abstract

Even skilled surgeons will have complications after antireflux surgery. Fortunately, the mortality is low (<1%) with laparoscopic surgery, immediate postoperative morbidity is uncommon (5%-20%), and conversion to an open operation is <2.5%. Common late postoperative complications include gas-bloat syndrome (up to 85%), dysphagia (10%-50%), diarrhea (18%-33%), and recurrent heartburn (10%-62%). Most of these complications improve during the 3-6 months after surgery. Dietary modifications, pharmacologic therapies, and esophageal dilation may be helpful. Failures after antireflux surgery usually occur within the first 2 years after the initial operation. They fall into 5 patterns: herniation of the fundoplication into the chest, slipped fundoplication, tight fundoplication, paraesophageal hernia, and malposition of the fundoplication. Reoperation rates range from 0%-15% and should be performed by experienced foregut surgeons.
Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23267868     DOI: 10.1016/j.cgh.2012.12.006

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  37 in total

1.  Optimal treatment of laryngopharyngeal reflux disease.

Authors:  Irene Martinucci; Nicola de Bortoli; Edoardo Savarino; Andrea Nacci; Salvatore Osvaldo Romeo; Massimo Bellini; Vincenzo Savarino; Bruno Fattori; Santino Marchi
Journal:  Ther Adv Chronic Dis       Date:  2013-11       Impact factor: 5.091

2.  A budget impact analysis of a magnetic sphincter augmentation device for the treatment of medication-refractory mechanical gastroesophageal reflux disease: a United States payer perspective.

Authors:  John Pandolfino; John Lipham; Amarpreet Chawla; Nicole Ferko; Andrew Hogan; Rana A Qadeer
Journal:  Surg Endosc       Date:  2019-09-26       Impact factor: 4.584

3.  Acute gastric dilation and necrosis as a late complication following laparoscopic Nissen fundoplication.

Authors:  Jordan M Cloyd; Alexander Moskovitz; John Stevenson
Journal:  Dig Dis Sci       Date:  2014-06-20       Impact factor: 3.199

Review 4.  [EndoStim® treatment-a new minimally invasive technology in antireflux surgery].

Authors:  D Stephan; S Attwood; J Labenz; F Willeke
Journal:  Chirurg       Date:  2018-10       Impact factor: 0.955

Review 5.  Laparoscopic fundoplication for gastroesophageal reflux disease.

Authors:  Marzio Frazzoni; Micaela Piccoli; Rita Conigliaro; Leonardo Frazzoni; Gianluigi Melotti
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 6.  [Chronic chest pain].

Authors:  G Görge; D Grandt; W Häuser
Journal:  Schmerz       Date:  2014-06       Impact factor: 1.107

7.  Gastric necrosis: A late complication of nissen fundoplication.

Authors:  Javier Salinas; Tihomir Georgiev; Juan Antonio González-Sánchez; Elena López-Ruiz; José Antonio Rodríguez-Montes
Journal:  World J Gastrointest Surg       Date:  2014-09-27

8.  Clinicopathology and Survival in Patients with Gastroesophageal Reflux After Radical Surgery of Proximal Gastric Cancer.

Authors:  Ke-Ming Ying; Zheng Chen; Cheng-Xue Dang; Min-Chang Sun; Gui-Ru Yan; Bing-Hua Kan; Zi-Seng Xu
Journal:  Dig Dis Sci       Date:  2018-02-03       Impact factor: 3.199

9.  Both Pre-Transplant and Early Post-Transplant Antireflux Surgery Prevent Development of Early Allograft Injury After Lung Transplantation.

Authors:  Wai-Kit Lo; Hilary J Goldberg; Jon Wee; P Marco Fisichella; Walter W Chan
Journal:  J Gastrointest Surg       Date:  2016-01       Impact factor: 3.452

10.  Magnetic sphincter augmentation and fundoplication for GERD in clinical practice: one-year results of a multicenter, prospective observational study.

Authors:  Martin Riegler; Sebastian F Schoppman; Luigi Bonavina; David Ashton; Thomas Horbach; Matthias Kemen
Journal:  Surg Endosc       Date:  2014-08-30       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.